Related references
Note: Only part of the references are listed.Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin
Oliver Koeberling et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana
Abraham Hodgson et al.
PLOS ONE (2008)
Postgenomics of Neisseria meningitidis for vaccines development
Giulia Bernardini et al.
EXPERT REVIEW OF PROTEOMICS (2007)
Functional and specific antibody responses in adult volunteers in new Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines
E. Wedege et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
David S. Stephens et al.
LANCET (2007)
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: Implications for the development of a multicomponent group B vaccine
Peter T. Beernink et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870
Oliver Koeberling et al.
VACCINE (2007)
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
Scott A. Halperin et al.
VACCINE (2007)
Prevention of meningococcal disease
Pierce Gardner
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid genetic grouping of factor H-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate
Peter T. Beernink et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens
S Jacobsson et al.
VACCINE (2006)
Towards an improved serogroup B Neisseria meningitidis vaccine
KP Perrett et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide
H Tiwana et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis
G Norheim et al.
VACCINE (2005)
Outbreak of invasive Haemophilus influenzae serotype a disease
LL Hammitt et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
MeNZB™:: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
P Oster et al.
VACCINE (2005)
The region comprising amino acids 100 to 255 of Neisseria meningitidis, lipoprotein GNA 1870 elicits bactericidal antibodies
MM Giuliani et al.
INFECTION AND IMMUNITY (2005)
Recent developments in Neisseria meningitidis group A conjugate vaccines
CE Frasch
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic
KH Dyet et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Rapid detection of Neisseria meningitidis in cerebrospinal fluid by one-step polymerase chain reaction of the nspA gene
L de Filippis et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
NadA diversity and carriage in Neisseria meningitidis
M Comanducci et al.
INFECTION AND IMMUNITY (2004)
Expression of heterologous antigens in commensal Neisseria spp.:: Preservation of conformational epitopes with vaccine potential
CA O'Dwyer et al.
INFECTION AND IMMUNITY (2004)
Distribution of surface protein variants among hyperinvasive meningococci: Implications for vaccine design
R Urwin et al.
INFECTION AND IMMUNITY (2004)
Conformational epitopes recognized by protective anti-neisserial surface protein a antibodies
VC Hou et al.
INFECTION AND IMMUNITY (2003)
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component
EAL Thompson et al.
MICROBIOLOGY-SGM (2003)
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains
GR Moe et al.
INFECTION AND IMMUNITY (2002)
Neisseria lactamica protects against experimental meningococcal infection
KJ Oliver et al.
INFECTION AND IMMUNITY (2002)
Current concepts in the role of the host response in Neisseria meningitidis septic shock
P Brandtzaeg et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2002)
Lipooligosaccharide and polysaccharide capsule:: Virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells
A Unkmeir et al.
INFECTION AND IMMUNITY (2002)
Vaccine prevention of meningococcal disease, coming soon?
SL Morley et al.
VACCINE (2001)
Medical progress: Meningococcal disease.
NE Rosenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine
SL Martin et al.
VACCINE (2000)
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys
ER van der Voort et al.
VACCINE (2000)
Share Paper
